Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients.

Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients.

Item
http://www.wikidata.org/entity/Q40849659
New developments in the treatment of gram-negative bacteremia.Increased aminoglycoside dosage requirements in hematologic malignancy.Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy.Randomized comparison between two ceftazidime-containing regimens and cephalothin-gentamicin-carbenicillin in febrile granulocytopenic cancer patients.Comparative activities of piperacillin, ceftazidime, and amikacin, alone and in all possible combinations, against experimental Pseudomonas aeruginosa infections in neutropenic rats.Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patientsProspective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infectionsComparison of the effects of mezlocillin, carbenicillin, and placebo on normal hemostasis.Infections in acute leukemia: a retrospective study of 148 patientsImipenem-antibiotic monotherapy in juvenile cancer patients with neutropenia.Role of pharmacokinetics in the outcome of infections.Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients.Piperacillin plus vancomycin in the therapy of febrile episodes in cancer patientsBactericidal activity of ceftazidime in serum compared with that of ticarcillin combined with amikacin.Piperacillin sodium: antibacterial spectrum, pharmacokinetics, clinical efficacy, and adverse reactions.The efficacy of mezlocillin-amikacin combination in febrile neutropenic children with oncologic disease.Moxalactam-tobramycin-resistant Pseudomonas aeruginosa isolates in patients with cystic fibrosis.
P2860

Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients.

Item
http://www.wikidata.org/entity/Q40849659
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年学术文章
@wuu
1981年学术文章
@zh-cn
1981年学术文章
@zh-hans
1981年学术文章
@zh-my
1981年学术文章
@zh-sg
1981年學術文章
@yue
1981年學術文章
@zh
1981年學術文章
@zh-hant
name
Piperacillin or ticarcillin pl ...... nulocytopenic cancer patients.
@en
type
label
Piperacillin or ticarcillin pl ...... nulocytopenic cancer patients.
@en
prefLabel
Piperacillin or ticarcillin pl ...... nulocytopenic cancer patients.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Piperacillin or ticarcillin pl ...... nulocytopenic cancer patients.
@en
P2093
P304
P31
P356
10.1016/0002-9343(81)90324-7
P407
P433
P478
P577
P698